全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:Lucy Dorey , Peter Lees
来源:[J].BMC Veterinary Research(IF 1.861), 2017, Vol.13 (1)Springer
摘要:The most widely used measure of potency of antimicrobial drugs is Minimum Inhibitory Concentration (MIC). MIC is usually determined under standardised conditions in broths formulated to optimise bacterial growth on a species-by-species basis. This ensures comparability of data be...
作者:Lucy Dorey , Ludovic Pelligand , Peter Lees
来源:[J].BMC Veterinary Research(IF 1.861), 2017, Vol.13 (1)Springer
摘要:Bacterial pneumonia in pigs occurs widely and requires antimicrobial therapy. It is commonly caused by the pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida . Marbofloxacin is an antimicrobial drug of the fluoroquinolone class, licensed for use against these org...
作者:Peter Lees , Aude A. Ferran
来源:[J].Clinical Pharmacokinetics(IF 6.109), 2020, Vol.59 (1), pp.1-5Springer
摘要:At the request of French Regulatory Authorities, a new formulation of Levothyrox was licensed in France in 2017, with the objective of avoiding the stability deficiencies of an existing licensed formulation. Before launching the new formulation, an average bioequivalence (AB...
作者:Peter Lees , Fariborz Shojaee Aliabadi
来源:[J].International Journal of Antimicrobial Agents(IF 4.415), 2002, Vol.19 (4), pp.269-284Elsevier
摘要:Abstract(#br)The rational dosing of antimicrobial drugs depends on knowledge of physiology, anatomy and pathology, including disease condition, and in major respects these differ between animals and humans and between species of animal. These differences lead to species vari...
作者:Peter Lees , Edward Gabrielson ...
来源:[J].Environmental Research(IF 3.238), 2018, Vol.161, pp.304-313Elsevier
摘要:Abstract(#br)Background(#br)Exposure to particulate matter (PM) is increasing worldwide as a result of increased human activity, the rapid industrialization of developing countries, and effects of climate change. Adverse effects of PM on human health are well documented, and beca...
作者:Peter Lees , Aude Ferran
来源:[J].Clinical Pharmacokinetics(IF 6.109), 2019, Vol.58 (7), pp.827-833Springer
摘要:Abstract(#br)In France, more than 2.5 million patients are currently treated with levothyroxine, mainly as the marketed product Levothyrox ® . In March 2017, at the request of French authorities, a new formulation of Levothyrox ® was licensed, with the objective of avoiding ...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×